Shelter Mutual Insurance’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-36,300
Closed -$560K 46
2018
Q4
$560K Hold
36,300
0.18% 45
2018
Q3
$782K Hold
36,300
0.22% 45
2018
Q2
$883K Sell
36,300
-4,100
-10% -$83.6K 0.26% 44
2018
Q1
$690K Hold
40,400
0.21% 42
2017
Q4
$765K Hold
40,400
0.23% 41
2017
Q3
$711K Buy
40,400
+36,400
+910% +$819K 0.22% 42
2017
Q2
$133K Buy
+4,000
New +$124K 0.04% 42
2017
Q1
Sell
-44,100
Closed -$1.6M 43
2016
Q4
$1.6M Hold
44,100
0.49% 39
2016
Q3
$2.03M Hold
44,100
0.63% 39
2016
Q2
$2.21M Hold
44,100
0.67% 40
2016
Q1
$2.36M Hold
44,100
0.72% 41
2015
Q4
$2.9M Hold
44,100
0.9% 36
2015
Q3
$2.49M Hold
44,100
0.82% 37
2015
Q2
$2.61M Hold
44,100
0.78% 38
2015
Q1
$2.75M Buy
44,100
+40,100
+1,003% +$2.33M 0.86% 37
2014
Q4
$230K Sell
4,000
-40,100
-91% -$2.23M 0.06% 42
2014
Q3
$2.37M Hold
44,100
0.65% 41
2014
Q2
$2.33M Hold
44,100
0.64% 41
2014
Q1
$2.33M Hold
44,100
0.64% 43
2013
Q4
$1.77M Hold
44,100
0.47% 47
2013
Q3
$1.67M Hold
44,100
0.48% 47
2013
Q2
$1.73M Buy
+44,100
New +$1.72M 0.51% 47

Other funds holding TEVA

Shelter Mutual Insurance's TEVA Position: Q1 2019 in Review

Shelter Mutual Insurance sold out of Teva Pharmaceuticals (TEVA) in Q1 2019, closing a stake of 36,300 shares — an estimated $560K sold.

Shelter Mutual Insurance first reported a position in TEVA in Q2 2013 and held it in 22 quarters. The position peaked at $2.9M in Q4 2015. 522 funds tracked by Wall St. Rank hold TEVA as of Q1 2019.

  • Shelter Mutual Insurance reported no remaining Teva Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Shelter Mutual Insurance sold 36,300 Teva Pharmaceuticals shares in Q1 2019, an estimated $560K.
  • Shelter Mutual Insurance first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 22 quarters.
  • Shelter Mutual Insurance's Teva Pharmaceuticals position peaked at $2.9M in Q4 2015.
  • 522 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2019.

Based on Shelter Mutual Insurance's 13F filing for Q1 2019, filed 22 Apr 2019.